Lipton RB, et al. Patient Global Impression of Change related to improvement in most bothersome symptom following treatment with eptinezumab. IHC-PO-167. IHC 2019, 5-8 sept. Dublin, Ierland.
Glatirameeracetaat: ook risico op anafylactische reacties lang na start behandeling
sep 2024 | Multipele Sclerose